Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999

Clinica Chimica Acta

Volumn 413, Issue 19-20, 2012, Pages 1618-1624

  Shahabi, Payman ^a   Siest, Gérard ^a   Herbeth, Bernard ^a   Ndiaye, Ndeye Coumba ^a   Visvikis Siest, Sophie ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Biological variation factors; Genetic polymorphisms; Haptoglobin; Reference values; Rs2000999

Indexed keywords

ALPHA1 GLYCOPROTEIN; C REACTIVE PROTEIN; HAPTOGLOBIN; HEMOGLOBIN;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; ANALYTIC METHOD; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENDER; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPTOGLOBIN GENE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MALE; PHENOTYPE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; REFERENCE VALUE PARTITIONING; REGRESSION ANALYSIS; SCHOOL CHILD; SMOKING;

ADOLESCENT; ADULT; AGE FACTORS; ALLELES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PLASMA; POLYMORPHISM, GENETIC; REFERENCE VALUES; SEX FACTORS; SMOKING;

SANDFLY FEVER SICILIAN VIRUS;

EID: 84864379210     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.04.033     Document Type: Article

References (46)

1. Polonovski M., Jayle M.F. Existence dans le plasma sanguin d'une substance activant l'action peroxydasique de l'hemoglobine. C R Soc Biol 1938, 129:457-460.
2. Nielsen M.J., Moestrup S.K. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 2009, 114:764-771.
3. Teisberg P., Gjone E. Probable linkage of LCAT locus in man to the alpha haptoglobin locus on chromosome 16. Nature 1974, 249:550-551.
4. Wobeto V.P., Zaccariotto T.R., Sonati Mde F. Polymorphisms of human haptoglobin and its clinical importance. Genet Mol Biol 2008, 31:602-620.
5. Langlois M.R., Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996, 42:1589-1600.
6. Sadrzadeh S.M., Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 2004, 121:S97-S104. (Suppl.).
7. Quaye I.K. Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 2008, 102:735-742.
8. Levy A.P., Asleh R., Blum S., et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010, 12:293-304.
9. Jacobs M., van Greevenbroek M.M., van der Kallen C.J., et al. The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study. Eur J Clin Invest 2011, 41:167-175.
10. Vallianou N.G., Evangelopoulos A.A., Panagiotakos D.B., et al. Associations of acute-phase reactants with metabolic syndrome in middle-aged overweight or obese people. Med Sci Monit 2010, 16:CR56-CR60.
11. Suzuki K., Yagi K., Oka R., et al. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients. Clin Chem Lab Med 2009, 47:70-74.
12. Engström G., Janzon L., Berglund G., et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002, 22:2054-2058.
13. Pan J.P., Cheng T.M., Shih C.C., et al. Haptoglobin phenotypes and plasma haptoglobin levels in patients with abdominal aortic aneurysm. J Vasc Surg 2011, 53:1189-1194.
14. Engström G., Hedblad B., Tydén P., Lindgärde F. Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study. Atherosclerosis 2009, 202:617-622.
15. Holme I., Aastveit A.H., Hammar N., Jungner I., Walldius G. Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Ann Med 2009, 41:522-532.
16. Holme I., Aastveit A.H., Hammar N., Jungner I., Walldius G. Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Atherosclerosis 2010, 213:299-305.
17. Engström G., Lind P., Hedblad B., Stavenow L., Janzon L., Lindgärde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 2002, 105:2632-2637.
18. Engström G., Hedblad B., Stavenow L., et al. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study. Circulation 2004, 110:27-31.
19. Brunetti N.D., Padalino R., De Gennaro L., et al. Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment. J Thromb Thrombolysis 2009, 28:50-56.
20. Brea D., Sobrino T., Blanco M., et al. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation. Atherosclerosis 2009, 205:561-567.
21. Maes M., Cooreman W., Delanghe J., et al. Components of biological variation in plasma haptoglobin: relationships to plasma fibrinogen and immune variables, including interleukin-6 and its receptor. Clin Chim Acta 1995, 239:23-35.
22. Márquez L., Shen C., Cleynen I., et al. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. Gut 2012, 61:528-534.
23. Ritchie R.F., Palomaki G.E., Neveux L.M., Navolotskaia O. Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal 2000, 14:284-292.
24. Delanghe J.R., Langlois M.R., De Bacquer D., et al. Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis 2002, 160:471-476.
25. Haas B., Serchi T., Wagner D.R., et al. Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker. J Proteomics 2011, 75:229-236.
26. van Rijn H.J., van der Wilt W., Stroes J.W., Schrijver J. Is the turbidimetric immunoassay of haptoglobin phenotype-dependent?. Clin Biochem 1987, 20:245-248.
27. Kasvosve I., Gomo Z.A., Gangaidzo I.T., et al. Reference range of serum haptoglobin is haptoglobin phenotype-dependent in blacks. Clin Chim Acta 2000, 296:163-170.
28. Froguel P., Ndiaye N.C., Bonnefond A., et al. A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. PLoS One 2012, 7:e32327.
29. Visvikis-Siest S., Siest G. The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases. Clin Chem Lab Med 2008, 46:733-747.
30. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
31. Chatard J.C., Mujika I., Guy C., Lacour J.R. Anaemia and iron deficiency in athletes. Practical recommendations for treatment. Sports Med 1999, 27:229-240.
32. Lavoie M.E., Rabasa-Lhoret R., Doucet E., et al. Association between physical activity energy expenditure and inflammatory markers in sedentary overweight and obese women. Int J Obes (Lond) 2010, 34:1387-1395.
33. Haddy N., Sass C., Maumus S., et al. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet 2005, 13:109-117.
34. Leng S., Xue Q.L., Huang Y., et al. Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J Gerontol A Biol Sci Med Sci 2005, 60:195-199.
35. Shirts B.H., Wilson A.R., Jackson B.R. Partitioning reference intervals by use of genetic information. Clin Chem 2011, 57:475-481.
36. Cheng T.M., Lee T.C., Tseng S.H., Chu H.L., Pan J.P., Chang C.C. Human haptoglobin phenotypes and concentration determination by nanogold-enhanced electrochemical impedance spectroscopy. Nanotechnology 2011, 22:245105.
37. Shiflett A.M., Bishop J.R., Pahwa A., Hajduk S.L. Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes. J Biol Chem 2005, 280:32578-32585.
38. Bruun J.M., Lihn A.S., Madan A.K., et al. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 2004, 286:E8-E13.
39. Rodríguez G., Moreno L.A., Blay M.G., et al. Body composition in adolescents: measurements and metabolic aspects. Int J Obes Relat Metab Disord 2004, 28(Suppl. 3):S54-S58.
40. Troiano R.P., Berrigan D., Dodd K.W., Mâsse L.C., Tilert T., McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 2008, 40:181-188.
41. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
42. Ingenbleek Y., Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994, 14:495-533.
43. Faraj M., Lavoie M.E., Messier L., Bastard J.P., Prud'homme D. Reduction in serum apoB is associated with reduced inflammation and insulin resistance in post-menopausal women: A MONET study. Atherosclerosis 2010, 211:682-688.
44. Salvatore A., Cigliano L., Bucci E.M., et al. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Biochemistry 2007, 46:11158-11168.
45. Spagnuolo M.S., Cigliano L., D'Andrea L.D., Pedone C., Abrescia P. Assignment of the binding site for haptoglobin on apolipoprotein A-I. J Biol Chem 2005, 280:1193-1198.
46. Gallo R.L., Dorschner R.A., Takashima S., Klagsbrun M., Eriksson E., Bernfield M. Endothelial cell surface alkaline phosphatase activity is induced by IL-6 released during wound repair. J Invest Dermatol 1997, 109:597-603.